{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2011"],"condition":["Gastrointestinal Stromal Tumors"],"disease":["Gastrointestinal Stromal Tumors"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2099989"],"location":["Belgium"],"study_start_month":["1"],"keyword":["Regorafenib","GIST","Advanced","Gastro-intestinal","Metastatic","Stromal"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib","description":"The purpose of this study is to evaluate WB DWI as early predictor of response to treatment with regorafenib or placebo in patients with advanced metastatic GIST.","dates":{"creation":"2011-01-15"},"accession":"2099989","cross_references":{"ClinicalTrials___gov":["NCT01265979"]}}